Loading…

Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer

Xing X‐F, Li H, Zhong X‐Y, Zhang L‐H, Wang X‐H, Liu Y‐Q, Jia S‐Q, Shi T, Niu Z‐J, Peng Y, Du H, Zhang G‐G, Hu Y, Lu A‐P, Li J‐Y, Chen S & Ji J‐F 
(2011) Histopathology59, 198–206 Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer Aims:  The secreted phosph...

Full description

Saved in:
Bibliographic Details
Published in:Histopathology 2011-08, Vol.59 (2), p.198-206
Main Authors: Xing, Xiao-Fang, Li, Hong, Zhong, Xi-Yao, Zhang, Lian-Hai, Wang, Xiao-Hong, Liu, Yi-Qiang, Jia, Shu-Qin, Shi, Tao, Niu, Zhao-Jian, Peng, Yong, Du, Hong, Zhang, Gui-Guo, Hu, Ying, Lu, Ai-Ping, Li, Ji-You, Chen, She, Ji, Jia-Fu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Xing X‐F, Li H, Zhong X‐Y, Zhang L‐H, Wang X‐H, Liu Y‐Q, Jia S‐Q, Shi T, Niu Z‐J, Peng Y, Du H, Zhang G‐G, Hu Y, Lu A‐P, Li J‐Y, Chen S & Ji J‐F 
(2011) Histopathology59, 198–206 Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer Aims:  The secreted phospholipase A2 type IIA (PLA2G2A) gene has been identified as a modifier of intestinal adenoma multiplicity in ApcMin/+ mice. The aim of the present study was to analyse the clinical significance of PLA2G2A expression in human gastric cancer. Methods and results:  Using immunohistochemistry, cytoplasmic immunoreactivity of PLA2G2A was observed in 27% (40 of 149) of gastric cancer tissues compared with negative staining in normal mucosa. The PLA2G2A expression rate in well‐differentiated carcinoma was elevated significantly compared with that in poorly differentiated carcinoma (46% versus 19%, P = 0.001). Statistical analysis also revealed that PLA2G2A expression correlated negatively with depth of mural invasion, lymph node metastasis and tumour–node–metastasis (TNM) stage (P 
ISSN:0309-0167
1365-2559
DOI:10.1111/j.1365-2559.2011.03913.x